Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma

This publication has 35 references indexed in Scilit:

• Transcriptional diversity of long-term glioblastoma survivors
  Neuro-Oncology, 2014
• Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
  Journal of Neuro-Oncology, 2014
• Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations
  Clinical Cancer Research, 2013
• New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
  European Journal of Cancer, 2012
• Eosinophils in glioblastoma biology
  Journal of Neuroinflammation, 2012
• Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer
  European Journal of Cancer, 2009
• Malignant Gliomas in Adults
  New England Journal of Medicine, 2008
• Long-term survival with glioblastoma multiforme
  Brain, 2007
• Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience
  British Journal Of Neurosurgery, 2007
• 5-Year survival and clinical prognostic factors in progressive supratentorial diffuse “low-grade” astrocytoma: A retrospective analysis of 46 cases
  Acta Neurochirurgica, 1997